Drug recall · August 14, 2013
Piperacillin and Tazobactam for Injection recall
Why: Crystallization: Potential to exhibit precipitation/crystallization in IV bag or IV line upon reconstitution.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Piperacillin and Tazobactam for Injection, USP, 40.5 grams per Pharmacy Bulk Package vial, Rx only, Mfg. by: Hospira Healthcare India Pvt. Ltd., Irungattukottai - 602 105, India; Mfg. for: Apotex Corp., Weston, FL 33326, NDC 60505-0773-0
- Lots / codes
Lot No. 503B023, Exp. 08/13; 503B028, 503B029, 503B030, 503B031, 503B032, 503B033, Exp. 11/13; 503C001, 503C002, 503C003, 503C004, Exp. 12/13; 503C009, Exp. 01/14; 503C010, 503C011, 503C012, 503C014, Exp. 02/14; 503C015, 503C016, 503C017, 503C019, 503C020, Exp. 04/14
- Quantity
- 52,398 vials
- Company
- Apotex Corp., Weston, FL
- Distribution
- Nationwide
- Initiated
- May 10, 2013 · Voluntary: Firm initiated
- Classified
- August 2, 2013
- Reported
- August 14, 2013
- Ended
- January 8, 2018
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.